StonvexLoading…
StonvexStonvexStonvexCore line items from BSRR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $41.20M | $171.39M | $128.11M | $84.17M |
Operating Income | $16.73M | $56.34M | $39.21M | $26.50M |
Net Income | $12.52M | $42.33M | $29.43M | $19.73M |
EPS (Diluted) | $0.96 | $3.11 | $2.15 | $1.43 |
Total Assets | $3.75B | $3.83B | $3.71B | $3.77B |
Total Liabilities | $3.39B | $3.46B | $3.35B | $3.41B |
Cash & Equivalents | $156.37M | $135.63M | $95.50M | $130.01M |
Free Cash Flow OCF − CapEx | $10.98M | $32.17M | $18.63M | $3.93M |
Shares Outstanding | 13.09M | 13.27M | 13.48M | 13.68M |